No Data
No Data
Express News | Ardent Health Partners Inc : JP Morgan Raises Target Price to $19 From $18
NYSE New 52-Week Highs And Lows
Ardent Health to Participate in the Morgan Stanley 22nd Annual Global Healthcare Conference
Truist Financial Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Maintains Target Price $22
Truist Financial analyst David S Macdonald maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and maintains the target price at $22.According to TipRanks data, the analyst has a success
Truist Financial Sticks to Its Buy Rating for Ardent Health Partners, Inc. (ARDT)
Loop Capital Maintains Ardent Health Partners(ARDT.US) With Buy Rating, Raises Target Price to $21
Loop Capital analyst Timothy Greaves maintains $Ardent Health Partners(ARDT.US)$ with a buy rating, and adjusts the target price from $18 to $21.According to TipRanks data, the analyst has a success
No Data